Hopital St. Luc

Montreal, Quebec H2X 3J4

0 studies enrolling now · 2 studies all time

What they study most

Chronic Hepatitis C

Studies at this site

• Open-Label Study of Sofusbuvir+Ribavirin With or Without Peginterferon Alfa-2a in Subjects With Chronic HCV Infection Who Participated in Prior Gilead HCV Studies — Completed
• Sofosbuvir + Ribavirin for 12 or 16 Weeks in Treatment Experienced Subjects With Chronic Genotype 2 or 3 HCV Infection (FUSION) — Completed